Table 2. Association of known fasting insulin GWAS SNPs in the IGF1 region with fasting insulin levels without and with IGF1 levels as covariate in the model.
|
CHS |
FHS |
RS |
Meta |
Discovery papera |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | P | β | SE | P | β | SE | P | β | SE | P | β | SE | P | |
|
Model1: ln(FI)~SNP+age+sex+BMI | |||||||||||||||
| rs2114912:G>T | 0.020 | 0.024 | 0.41 | −0.039 | 0.015 | 0.01 | 0.002 | 0.093 | 0.98 | −0.021 | 0.013 | 0.09 | −0.024 | 0.004 | 3.4 × 10−11 |
| rs860598:G>A | 0.007 | 0.020 | 0.72 | −0.032 | 0.014 | 0.02 | −0.072 | 0.076 | 0.34 | −0.020 | 0.011 | 0.07 | −0.021 | 0.003 | 6.9 × 10−10 |
| rs35747:G>A | 0.005 | 0.019 | 0.81 | −0.032 | 0.014 | 0.02 | −0.079 | 0.079 | 0.32 | −0.021 | 0.011 | 0.06 | −0.021 | 0.004 | 8.9 × 10−10 |
| rs855213:A>G | 0.005 | 0.020 | 0.81 | −0.032 | 0.014 | 0.02 | −0.072 | 0.076 | 0.34 | −0.021 | 0.011 | 0.06 | −0.021 | 0.004 | 1.0 × 10−9 |
| rs35767:A>G | 0.013 | 0.020 | 0.50 | −0.031 | 0.015 | 0.04 | −0.127 | 0.080 | 0.11 | −0.017 | 0.012 | 0.15 | −0.022 | 0.004 | 2.4 × 10−9 |
| | |||||||||||||||
|
Model2: ln(FI)~SNP+age+sex+BMI+IGF1 | |||||||||||||||
| rs2114912:G>T | 0.018 | 0.024 | 0.45 | −0.039 | 0.015 | 0.01 | 0.004 | 0.094 | 0.97 | −0.022 | 0.013 | 0.08 | NA | NA | NA |
| rs860598:G>A | 0.004 | 0.020 | 0.85 | −0.032 | 0.014 | 0.02 | −0.071 | 0.077 | 0.36 | −0.020 | 0.011 | 0.07 | NA | NA | NA |
| rs35747:G>A | 0.001 | 0.019 | 0.95 | −0.033 | 0.014 | 0.02 | −0.078 | 0.080 | 0.33 | −0.022 | 0.011 | 0.05 | NA | NA | NA |
| rs855213:A>G | 0.002 | 0.020 | 0.94 | −0.032 | 0.014 | 0.02 | −0.071 | 0.077 | 0.36 | −0.023 | 0.011 | 0.05 | NA | NA | NA |
| rs35767:A>G | 0.010 | 0.020 | 0.61 | −0.031 | 0.015 | 0.04 | −0.125 | 0.081 | 0.12 | −0.018 | 0.012 | 0.13 | NA | NA | NA |
Abbreviations: CHS, Cardiovascular Health Study (n=1717); FHS, Framingham Heart Study (n=3293); RS, Rotterdam Study (n=140).
Manning et al5 (n up to 51 750).